447 related articles for article (PubMed ID: 18289228)
1. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic and electrolyte effects of hydroxyethyl starches in patients undergoing posterior lumbar interbody fusion using pedicle screws and cages.
Choi SJ; Ahn HJ; Chung SS; Kim MH; Choi DH; Lee SM; Kang JG; Kim JK
Spine (Phila Pa 1976); 2010 Apr; 35(7):829-34. PubMed ID: 20072091
[TBL] [Abstract][Full Text] [Related]
3. Impact of the C2/C6 ratio of high-molecular-weight hydroxyethyl starch on pharmacokinetics and blood coagulation in pigs.
Schramm S; Thyes C; Frascarolo P; Buclin T; Burki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
Anesthesiology; 2007 Sep; 107(3):442-51. PubMed ID: 17721247
[TBL] [Abstract][Full Text] [Related]
4. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
5. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery.
Boldt J; Schöllhorn T; Münchbach J; Pabsdorf M
Eur J Anaesthesiol; 2007 Mar; 24(3):267-75. PubMed ID: 17054812
[TBL] [Abstract][Full Text] [Related]
6. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis.
Niemi TT; Kuitunen AH
Acta Anaesthesiol Scand; 2005 Mar; 49(3):373-8. PubMed ID: 15752404
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of hydroxyethyl starch 6% 130/0.4 in a balanced electrolyte solution (Volulyte) during cardiac surgery.
Base EM; Standl T; Lassnigg A; Skhirtladze K; Jungheinrich C; Gayko D; Hiesmayr M
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):407-14. PubMed ID: 21345699
[TBL] [Abstract][Full Text] [Related]
8. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
9. [The in vivo molecular weight and renal threshold of hydroxyethyl starch in the example of molar substituted HES70/0/5].
Förster H; Lehmann G; Asskali F
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jan; 36(1):31-7. PubMed ID: 11227306
[TBL] [Abstract][Full Text] [Related]
10. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients.
Haisch G; Boldt J; Krebs C; Suttner S; Lehmann A; Isgro F
J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):316-21. PubMed ID: 11426361
[TBL] [Abstract][Full Text] [Related]
11. Changes in acid-base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 130/0.42/6 : 1 in normal saline or in balanced electrolyte solution in children.
Sümpelmann R; Witt L; Brütt M; Osterkorn D; Koppert W; Osthaus WA
Paediatr Anaesth; 2010 Jan; 20(1):100-4. PubMed ID: 19968805
[TBL] [Abstract][Full Text] [Related]
12. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids.
Roche AM; James MF; Bennett-Guerrero E; Mythen MG
Anesth Analg; 2006 Apr; 102(4):1274-9. PubMed ID: 16551936
[TBL] [Abstract][Full Text] [Related]
13. A new plasma-adapted hydroxyethyl starch preparation: in vitro coagulation studies.
Boldt J; Mengistu A
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):394-8. PubMed ID: 20005132
[TBL] [Abstract][Full Text] [Related]
14. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass.
Boldt J; Lehmann A; Römpert R; Haisch G; Isgro F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):264-8. PubMed ID: 10890478
[TBL] [Abstract][Full Text] [Related]
15. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
Kröll W; Pölz W; Colombo T; Steindorfer P
Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
[TBL] [Abstract][Full Text] [Related]
16. Do different substitution patterns or plant origin in hydroxyethyl starches affect blood coagulation in vitro?
Matsota P; Politou M; Kalimeris K; Apostolaki S; Merkouri E; Gialeraki A; Travlou A; Kostopanagiotou G
Blood Coagul Fibrinolysis; 2010 Jul; 21(5):448-51. PubMed ID: 20389236
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Acta Anaesthesiol Taiwan; 2009 Jun; 47(2):71-8. PubMed ID: 19527967
[TBL] [Abstract][Full Text] [Related]
18. [Changes in blood coagulation in treatment with hydroxyethyl starch].
Sefrin P; Rauch S; Zieglmeyer C
Anaesthesiol Reanim; 1998; 23(6):149-56. PubMed ID: 10036794
[TBL] [Abstract][Full Text] [Related]
19. The impact of a medium molecular weight, low molar substitution hydroxyethyl starch dissolved in a physiologically balanced electrolyte solution on blood coagulation and platelet function in vitro.
Boldt J; Mengistu A; Seyfert UT; Vogt A; Hellstern P
Vox Sang; 2007 Aug; 93(2):139-44. PubMed ID: 17683357
[TBL] [Abstract][Full Text] [Related]
20. Molecular weight of hydroxyethyl starch molecules influences coagulation profile measured by thrombelastography.
Felfernig M; Virmani S; Weintraud M; Oberndorfer U; Zimpfer M; Veen H; Blaicher AM
J R Nav Med Serv; 2008; 94(1):7-13. PubMed ID: 18524134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
